Back to Home
Recursion Pharmaceuticals news
Recursion Pharmaceuticals appears in 1 story we have published in September 2026, mostly in our Business coverage. It is most often reported alongside Catalio Capital Management, Enveda and Iconiq.
Latest development
Enveda Raises $311M at $2B Valuation to Advance AI-Discovered Drugs
Enveda, a biotech startup using AI to discover drugs from natural sources, has raised $311 million in a Series E funding round at a $2 billion valuation. The company is advancing multiple AI-discovered drug candidates into clinical trials, marking a significant milestone for the intersection of AI and biotechnology.
24 September 2026
